How to Capitalize on the $1 Billion Hemp Industry


Ryan Allway

September 11th, 2017

Exclusive, News, Top News


The cannabis industry may be on track to surpass $50 billion by 2026, but that doesn’t mean that investors should ignore the nascent hemp industry. With a projected 55% compound annual growth rate, the hemp industry is projected to surpass $1 billion in just three years. Analysts are bullish on the prospects for the industry, but note that there are few companies that have generated tangible revenues in the space.

In this article, we will look at a company that’s uniquely positioned to capitalize on the market for hemp-based cannabidiol (CBD) and how investors can build a stake.

Hemp Set to Grow 55% Each Year to $1 Billion

The cannabis industry is projected to reach $50 billion by 2026, according to Cowen & Co., driven by the legalization of recreational marijuana in California and Nevada. In addition to state-wide legalization, there are signs that the federal government could reverse its standing on medical marijuana under President Trump. A reclassification of the drug could lead to significant involvement from the multi-billion dollar pharmaceutical industry.

While tetrahydrocannabinol (THC) gets most of the attention, a growing body of research has been focused on non-psychoactive cannabidiol (CBD). CBD has shown early promise in treating everything from Alzheimer’s diseases to stroke and traumatic brain injury. GW Pharmaceutical plc (NASDAQ: GWPH) has also successfully conducted clinical trials of Sativex – a whole-plant CBD-rich extract – for patients suffering from neuropathic pain.

A new report by Brightfield Group projects that the hemp-derived cannabidiol market will be a billion-dollar market in three years. Brightfield estimates that hemp-based CBD sales surpassed $170 million last year and projects 55% compound annual growth that will increase that figure past the $1 billion mark. A key benefit of CBD over THC is that the cannabinoid is non-psychoactive and can be derived from hemp plants which makes it legal to sell anywhere.

Medical Marijuana Inc.’s Unique Advantage

Brightfield anticipates strong growth in the hemp-based CBD market, but not all companies are created equally in the space. According to Bethany Gomez, the Director of Research at Brightfield Group, in a recent press release announcing the report, “One of the most surprising things we found during this research was how many companies are currently operating in the space, and how few of them are generating significant revenue.”

There are several public companies involved in the hemp-based CBD space, but Medical Marijuana Inc. (OTC Pink: MJNA) is one of the few generating significant revenue. During the second quarter, the company reported gross revenue that increased 269% to $6,131,415 driven by its Kannaway® division that reported its single largest revenue month ever. Kannaway® is the company’s marketing arm focused on selling CBD products.

“We are confident that Kannaway® is on a trajectory to exceed expectations,” said Kannaway® CEO Black Schroeder. “We are proud to be a part of the Medical Marijuana Inc. family, which actively supports efforts to increase access to cannabidiol (CBD) products worldwide.”

In addition to Kannaway®, the company owns several other subsidiaries involved in the CBD space. These businesses include its HempMeds business focused on the development of hemp-based CBD products worldwide and its stake in AXIM Biotechnologies Inc. (OTCQB: AXIM), a pharmaceutical company developing chewable cannabidiol products designed to treat a number of underlying medical conditions with the cannabinoid.

Looking Ahead

Medical Marijuana Inc. (OTC Pink: MJNA) is uniquely positioned in the hemp-based CBD industry with its Kannaway® over-the-counter line-up and its stake in the pharmaceutical side of the space. Investors may want to keep a close eye on the stock moving into the third quarter as its businesses and subsidiaries continue to strengthen in the industry.

For more information, visit the company’s website or CannabisFN’s company profile.

Ryan Allway

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media

CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and brands in the US and Canada rely on CFN Media to grow and succeed.

CFN launched in June of 2013 to initially serve the growing universe of publicly traded marijuana companies across North America. Today, CFN Media is also the digital media choice for the emerging brands in the space.

Learn How Your Company can Be Covered on CFN Media

Learn More About the CFN Media Sponsored Content Program

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: http://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.

Copyright © TDM Financial LLC · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading